An endoluminal sleeve induces substantial weight loss and normalizes glucose homeostasis in rats with diet-induced obesity

Obesity

Volumn 16, Issue 12, 2008, Pages 2585-2592

  Aguirre, Vincent ^a   Stylopoulos, Nicholas ^a   Grinbaum, Ronit ^a   Kaplan, Lee M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; INSULIN;

ANIMAL; ANIMAL MODEL; ARTICLE; BARIATRIC SURGERY; BLOOD; CALORIC INTAKE; CHEMISTRY; DIET; FECES; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; IMPLANT; INSULIN RESISTANCE; INTESTINE ABSORPTION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; METABOLISM; METHODOLOGY; OBESITY; PANCREAS ISLET BETA CELL; RAT; ROUX Y ANASTOMOSIS; SMALL INTESTINE; SPRAGUE DAWLEY RAT; WEIGHT REDUCTION;

ANASTOMOSIS, ROUX-EN-Y; ANIMALS; BARIATRIC SURGERY; BLOOD GLUCOSE; DIET; ENERGY INTAKE; FECES; GHRELIN; HOMEOSTASIS; IMPLANTS, EXPERIMENTAL; INJECTIONS, INTRAPERITONEAL; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; INTESTINAL ABSORPTION; INTESTINE, SMALL; MALE; MODELS, ANIMAL; OBESITY; RATS; RATS, SPRAGUE-DAWLEY; WEIGHT LOSS;

ANIMALIA; RATTUS;

EID: 58149279479     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.502     Document Type: Article

References (39)

1. Mokdad A,H Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2001 ;286:1195-1200.
2. USDHHS. Prevalence of obesity among U.S. adults. The Surgeon General's call to action to prevent and decrease overweight and obesity. USDHHS, Public Health Service, Office of the Surgeon General, U.S. Government Printing Office: Washington, D.O., 2001.
3. Finkelstein EA, Fiebelkorn IC, Wang G. National medical spending attributable to overweight and obesity: how much, and who's paying? Health Aff (Millwood) 2003 Jan-Jun; Suppl Web Exclusives: W3-219-226.
4. Kaplan LM. Gastrointestinal management of the bariatric surgery patient. Gastroenterol Clin NAm 2005;34:105-125.
5. Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724-1737.
6. Cummings DE, Overduin J. Gastrointestinal regulation of food Intake. J Clin Invest 2007;117:13-23.
7. Kaplan LM. Body weight regulation and obesity. J Gastrointest Surg 2003;7:443-451.
8. Murphy KG, Bloom SR. Gut hormones In the control of appetite. Exp Physiol 2004;89:507-516.
9. Stylopoulos N, Davis P, Pettit JD et al. Changes In serum ghrelln predict weight loss after Roux-en-Y gastric bypass In rats. Surg Endosc 2005;19:942-946.
10. Ie Roux CW, Aylwin SJ, Batterham RL et al. Gut hormone profiles following barlatrlc surgery favor an anorectic state, facilitate weight loss, and Improve metabolic parameters. Ann Surg 2006;243:108-114.
11. Strader AD, Seeley RJ. Gastrointestinal hormones and food Intake. Gastroenterology 2005;128:175-191.
12. Baldinger M, Rubin R, Wright N et al. Change In hunger, fullness, ghrelin, PYY, and GLP-1 In relation to a fixed test meal pre and post Roux-en-Y gastric bypass (RYGBS). Appetite 2007;49:277.
13. Rubino F. Bariatric surgery: effects on glucose homeostasis. Curr Opin Clin Nutr Metab Care 2006;9:497-507.
14. Guijarro A, Kirchner H, Meguld MM. Catabolic effects of gastric bypass In a diet-Induced obese rat model. Curr Opin Clin Nutr Metab Care 2006;9: 423-435.
15. Wren AM, Bloom SR. Gut hormones and appetite control. Gastroenterology 2007;132:2116-2130.
16. Bagglo LL, Drucker DJ. Biology of incretins: GLP-1 and GIR Gastroenterology 2007;132:2131 -2157.
17. Strader AD, Vahl TP, Jandacek RJ et al. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis In rats. Am J Physiol Endocrinol Metab 2005;288:E447-E453.
18. Patriti A, Aisa MC, Annette C et al. How the hindgut can cure type 2 diabetes. ileal transposition Improves glucose metabolism and beta-cell function In Goto-Kakizaki rats through enhanced proglucagon gene expression and L-cell number. Surgery 2007;142:74-85.
19. Koopmans HS, Ferri GL, Sarson DL et al. The effects of ileal transposition and jejunoileal bypass on food Intake and Gl hormone levels In rats. Physiol Behav 1984;33:601-609.
20. Suzuki S, Ramos EJ, Goncalves CG et al. Changes in Gl hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass In rat model. Surgery 2005;138:283-290.
21. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004;239:1-11.
22. Guijarro A, Suzuki S, Chen C et al. Characterization of weight loss and weight regain mechanisms after Roux-en-Y gastric bypass in rats. Am J Physiol Regul lntegr Comp Physiol 2007;293:R1474-R1489.
23. Rubino F, Forgione A, Cummings DE et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine In the pathophysiology of type 2 diabetes. Ann Surg 2006;244:741-749.
24. Milone L, Gagner M, Ueda K et al. Effect of a polyethylene endoluminal duodeno-jejunal tube (EDJT) on weight gain: a feasibility study In a porcine model. Obes Surg 2006;16:620-626.
25. Tarnoff M, Shikora S, Lembo A et al. Chronic In vivo experience with an endoscoploally delivered and retrieved duodenal-jejunal bypass sleeve In a porcine model. Surg Endosc 2008;22:1023-1028.
26. Gersin KS, Keller JE, Stefanidis D et al. Duodenal-jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity. Surg Innov 2007;14:275-278.
27. Rodrlguez-Grunert L, Galvao Neto MP, Alamo M et al. First human experience with endoscoploally delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis 2008;4:55-59.
28. Tarnoff M, Shikora S, Lembo A. Acute technical feasibility of an endoscopic duodenal-jejunal bypass sleeve In a porcine model: a potentially novel treatment for obesity and type 2 diabetes. Surg Endosc 2008;22:772-776.
29. Levin BE, Dunn-Meynell AA, Balkan B et al. Selective breeding for diet-induced obesity and resistance In Sprague-Dawley rats. Am J Physiol 1997;273:R725-R730.
30. Atkinson RL, Brent EL, Wagner BS et al. Energy balance and regulation of body weight after intestinal bypass surgery In rats. Am J Physiol 1983;245:R658-R663.
31. Schemmel R, Mickelsen O, Gill JL. Dietary obesity In rats: Body weight and body fat accretion in seven strains of rats. J Nutrition 1970; 100:1041 -1048.
32. Matthews DR, Hosker AS, Rudenskl AS et al. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations In man. Diabetologia 1985;28:412-419.
33. Hansen T, Volund A, Drivshoim T et al. The BIGTT Test: A novel test for simultaneous measurement of pancreatic β-cell function, insulin sensitivity, and glucose tolerance. Diabetes Care 2007;30:257-262.
34. Williams DL, Cummlngs DE, Grill HJ et al. Meal-related ghrelin suppression requires postgastric feedback. Endocrinology 2003;144:2765-2767.
35. Overduin J, Frayo RS, Grill HJ et al. Role of the duodenum and macronutrient type In ghrelin regulation. Endocrinology 2005;146:845-850.
36. Yin J, Chen J. Inhibitory effects of gastric electrical stimulation on ghrelinInduced excitatory effects on gastric motility and food Intake In dogs. Scand J Gastroenterol 2006;41:903-909.
37. Xing J, Brady F, Brodsky J et al. Gastric electrical stimulation effects on canine gastric emptying, food intake, and body weight. Obes Res 2003;11:41-47.
38. Obici S, Rossetti L. Minireview: Nutrient sensing and the regulation of insulin action and energy balance. Endocrinology 2003;144:5172-5178.
39. Cota D, Prouix K, Seeley RJ. The role of CNS fuel sensing In energy and glucose regulation. Gastroenterology 2007;132:2158-2168.